1. Gesenhues T, Hackenberg R, Diechert U, Duda V, Sturm G, Schulz KD . New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex. Geburtshilfe. Frauenheilkd 1989; 49 Suppl 1:96–8.
2. Andersen J, Grine E, Eng CL Y, et al. Expressin of connexin-43 inhuman myometrium and leiomyoma. Am J Obstet Gynecol 1993; 169:1266–76.
3. Rein MS, Barbieri RL, Friedman AJ . Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172(1 Pt 1):14–8.
4. Wu J, Cheng Y . Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations. Chung Hua Fu Chan Ko Tsa Chih 1995; 30(10):603–7.
5. Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995; 80(6):1876–81.